“Role of RANKL in cancer-induced bone disease and mammary tumorigenesis: preclinical evidence and clinical development of a RANKL Inhibitor”
Event details
| Date | 30.04.2010 |
| Hour | 10:15 |
| Speaker | Bill Dougall, Scientific Director, Amgen |
| Location | |
| Category | Conferences - Seminars |
Practical information
- General public
- Free
Contact
- Cathrin Brisken